Functional characterization of human CTC 1 mutations reveals novel mechanisms responsible for the pathogenesis of the telomere disease Coats plus
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary: C oats plus is a rare recessive disorder characterized by intracranial calcifications, hematological abnormalities, and retinal vascular defects. This disease results from mutations in CTC 1, a member of the CTC 1–STN 1–TEN 1 (CST) complex critical for telomere replication. Telomeres are specialized DNA/protein structures essential for the maintenance of genome stability. Several patients with C oats plus display critically shortened telomeres, suggesting that telomere dysfunction plays an important role in disease pathogenesis. These patients inherit CTC 1 mutations in a compound heterozygous manner, with one allele encoding a frameshift mutant and the other a missense mutant. How these mutations impact upon telomere function is unknown. We report here the first biochemical characterization of human CTC 1 mutations. We found that all CTC 1 frameshift mutations generated truncated or unstable protein products, none of which were able to form a complex with STN 1–TEN 1 on telomeres, resulting in progressive telomere shortening and formation of fused chromosomes. Missense mutations are able to form the CST complex at telomeres, but their expression levels are often repressed by the frameshift mutants. Our results also demonstrate for the first time that CTC 1 mutations promote telomere dysfunction by decreasing the stability of STN 1 to reduce its ability to interact with DNA P olα, thus highlighting a previously unknown mechanism to induce telomere dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“Autosomal dominant and recessive forms of this disease are due to mutations in hTERC and hTERT, respectively (Vulliamy et al., 2001, 2004), while X-linked DC is a result of mutations in Dyskerin (DC1), a small nuclear RNA–binding protein that interacts with TERC and is required for telomerase…”
BackgroundProtection of telomeres through independent control of ATM and ATR by TRF2 and POT1
Denchi, E. L., & de Lange, T. (2007) · Nature · doi:10.1038/nature06065 · Cited by 880
Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I. (2004) · Nature Genetics · doi:10.1038/ng1346 · Cited by 461 · cited 1×
“Autosomal dominant and recessive forms of this disease are due to mutations in hTERC and hTERT, respectively (Vulliamy et al., 2001, 2004), while X-linked DC is a result of mutations in Dyskerin (DC1), a small nuclear RNA–binding protein that interacts with TERC and is required for telomerase…”
BackgroundWu, L., Multani, A. S., He, H., Cosme-Blanco, W., Deng, Y., Deng, J. M., Bachilo, O., Pathak, S., Tahara, H., Bailey, S. M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.037 · Cited by 422 · cited 1×
“The proper positioning of POT1 on telomeres is necessary to prevent the initiation of an ATR-dependent DDR at telomeres (He et al., 2006, 2009; Hockemeyer et al., 2006; Wu et al., 2006; Denchi & de Lange, 2007; Guo et al., 2007).”
BackgroundSelf-citationSavage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 1×
“Mutations in the shelterin component TIN2 result in a very severe form of DC, with patients bearing very short telomeres and displaying premature BM failure as early as 10 years of age, even though telomerase function remains intact (Savage et al., 2008; Walne et al., 2008).”
BackgroundMiyake, Y., Nakamura, M., Nabetani, A., Shimamura, S., Tamura, M., Yonehara, S., Saito, M., & Ishikawa, F. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.009 · Cited by 350
Walne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008) · Blood · doi:10.1182/blood-2008-05-153445 · Cited by 317 · cited 1×
“Mutations in the shelterin component TIN2 result in a very severe form of DC, with patients bearing very short telomeres and displaying premature BM failure as early as 10 years of age, even though telomerase function remains intact (Savage et al., 2008; Walne et al., 2008).”
BackgroundDysfunctional telomeres activate an ATM‐ATR‐dependent DNA damage response to suppress tumorigenesis
Guo, X., Deng, Y., Lin, Y., Cosme‐Blanco, W., Chan, S., He, H., Yuan, G., Brown, E. J., & Chang, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601893 · Cited by 258
Self-citationEffect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells
Allsopp, R. C., Morin, G. B., Horner, J. W., DePinho, R., Harley, C. B., & Weissman, I. L. (2003) · Nature Medicine · doi:10.1038/nm0403-369 · Cited by 155 · cited 1×
“Critical telomere shortening results in proliferative defects in hematopoietic stem cells, leading to the onset of bone marrow (BM) failure syndromes (Allsopp et al., 2003).”
BackgroundCTC1 Mutations in a patient with dyskeratosis congenita
Keller, R. B., Gagne, K. E., Usmani, G. N., Asdourian, G. K., Williams, D. A., Hofmann, I., & Agarwal, S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24193 · Cited by 138 · cited 8×
“Numbers correspond to the number of patients found to possess these compound mutations (Anderson et al., 2012; Keller et al., 2012; Polvi et al., 2012; Walne et al., 2012).”
BackgroundResultInfluential
Cited by
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 304
Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization
Lim, C. J., & Cech, T. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00328-y · Cited by 273
The structure of human CST reveals a decameric assembly bound to telomeric DNA
Lim, C. J., Barbour, A. T., Zaug, A. J., Goodrich, K. J., McKay, A. E., Wuttke, D. S., & Cech, T. R. (2020) · Science · doi:10.1126/science.aaz9649 · Cited by 111
Structures of the human CST-Polα–primase complex bound to telomere templates
He, Q., Lin, X., Chavez, B. L., Agrawal, S., Lusk, B. L., & Lim, C. J. (2022) · Nature · doi:10.1038/s41586-022-05040-1 · Cited by 68
Metadata
- Authors
- Gu, P., & Chang, S.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2013-09-04
- Volume
- 12
- Issue
- 6
- Pages
- 1100-1109
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W2054896227
- Cited by
- 73
- References
- 10
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.